Endoscopic Resection of Gastrointestinal Neoplasms
Retrospective Study of Efficacy and Safety of the Endoscopic Removal of Cancerous and Precancerous Lesions of the Upper and Lower Digestive Tract
Sponsor: Azienda USL Reggio Emilia - IRCCS
Listed as NCT04780256, this observational or N/A phase trial focuses on Colonic Neoplasms and Duodenal Neoplasms and remains actively recruiting participants. Sponsored by Azienda USL Reggio Emilia - IRCCS, it has been updated 7 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Nov 2025 — Present [monthly]
Recruiting
Status: Unknown → Recruiting
-
Apr 2025 — Nov 2025 [monthly]
Unknown
-
Sep 2024 — Apr 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Sep 2021 — Aug 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda USL Reggio Emilia - IRCCS
For direct contact, visit the study record on ClinicalTrials.gov .